The 2016 European Journal of Pain conducted a study on rat models to test the effectiveness of CBD against arthritis in order to see if it could serve as an all-natural alternative to the typical arthritis pain medications, which are often tied with numerous uncomfortable and frustrating side effects. The rats were treated for 4 days with 4 different doses of CBD gel, and the results were quite staggering.
Cannabidiol is currently a class B1 controlled drug in New Zealand under the Misuse of Drugs Act. It is also a prescription medicine under the Medicines Act. In 2017 the rules were changed so that anyone wanting to use it could go to the Health Ministry for approval. Prior to this, the only way to obtain a prescription was to seek the personal approval of the Minister of Health.